<DOC>
	<DOCNO>NCT00004914</DOCNO>
	<brief_summary>RATIONALE : Exercise may decrease anemia-related fatigue , improve strength , build lose muscle tissue . Epoetin alfa may help improve cancer-related anemia , energy level , quality life . Exercise plus epoetin alfa may effective treatment anemia-related fatigue . PURPOSE : Phase II trial study effectiveness exercise plus epoetin alfa treat cancer patient anemia-related fatigue .</brief_summary>
	<brief_title>Exercise Plus Epoetin Alfa Treating Cancer Patients Who Have Anemia-Related Fatigue</brief_title>
	<detailed_description>OBJECTIVES : I . Determine effect progressive resistance training epoetin alfa lean body mass , fatigue , exercise tolerance , functional capacity , total body weight cancer patient anemia related fatigue . OUTLINE : Patients undergo progressive resistance training ( PRT ) consist 3 set 8 repetition concentric ( lift ) eccentric ( lower ) exercise 4-6 second use bench press , arm pull , knee extension , knee flexion , double leg press follow 1-2 minute rest set . Patients undergo warm cool period 10 minute prior follow PRT . Patients perform PRT 3 time week 12 week . Patients also receive epoetin alfa subcutaneously weekly 4-12 week absence unacceptable toxicity . PROJECTED ACCRUAL : A total 30 patient accrue study 15 month .</detailed_description>
	<mesh_term>Anemia</mesh_term>
	<mesh_term>Fatigue</mesh_term>
	<mesh_term>Epoetin Alfa</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Diagnosis nonmyeloid malignancy cancer relate fatigue Anemia ( hemoglobin le 10 g/dL ) No clinical radiographic evidence lytic bone metastases PATIENT CHARACTERISTICS : Age : Over 18 Performance status : ECOG 02 Life expectancy : Greater 4 month Hematopoietic : See Disease Characteristics Hepatic : Not specify Renal : Not specify Other : No dementia evidence mental incompetence No physical handicap preclude aerobic resistance exercise No clinical abnormality would render exercise risk HIV negative No contraindication epoetin alfa Not pregnant nursing Negative pregnancy test PRIOR CONCURRENT THERAPY : Biologic therapy : At least 8 week since prior epoetin alfa Chemotherapy : Concurrent chemotherapy allow Endocrine therapy : Not specify Radiotherapy : Concurrent radiotherapy allow Surgery : Not specify Other : Concurrent anticancer therapy allow At least 1 month since prior strength training great 3 hour week</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2012</verification_date>
	<keyword>unspecified adult solid tumor , protocol specific</keyword>
	<keyword>anemia</keyword>
	<keyword>fatigue</keyword>
</DOC>